Combined estradiol and lithium increase ER-alpha mRNA in embryonic C57BL/6J primary hippocampal cultures.
Estrogen replacement therapy (ERT) is commonly prescribed during menopause. Post-menopausal women also tend to suffer from bipolar disorders and as a result are prescribed mood stabilizers - in addition to ERT. There is a paucity of data on how combined hormones and mood stabilizers interact in regulating gene expression that led us to hypothesize that in primary cultures of mixed brain cells predominated by glia, combined 17beta-estradiol (E2) and lithium chloride (LiCl) (E2÷LiCl) will alter estrogen receptor-alpha (ER-alpha) mRNA expression. We quantified mRNA expression of ER-alpha using the cDNA of treated primary cultures of mixed brain cells from a previous study. Our results indicate that hippocampal cultures predominated by glia increase in ER-alpha mRNA expression when treated for 48 h with combined E2÷LiCl. Our findings may encourage further investigation on the molecular mechanisms involved in combined estrogen and lithium treatment.
Valdés
James J
JJ
Department of Biological Sciences, Florida International University, Florida, USA.
Weeks
Ophelia I
OI
D000818:Animals; D004958:Estradiol / Q000494:pharmacology*; D047628:Estrogen Receptor alpha / Q000096:biosynthesis*; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism*; D007150:Immunohistochemistry; D018021:Lithium Chloride / Q000494:pharmacology*; D051379:Mice; D008810:Mice, Inbred C57BL; D009924:Organ Culture Techniques; D012333:RNA, Messenger / Q000096:biosynthesis*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D047628:Estrogen Receptor alpha; D012333:RNA, Messenger; D004958:Estradiol; D018021:Lithium Chloride